The Effects of Delayed Appropriate Antimicrobial Therapy on Children with Staphylococcus Aureus Blood Infection

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 2024 Jun 14

PMID 38874791

Authors

Ziyao Guo

Ximing Xu

Guangli Zhang

Xingmei Wang

Xiaoyin Tian

Yuanyuan Li

Qinyuan Li

Dapeng Chen

Zhengxiu Luo

Affiliations

Soon will be listed here.

Abstract

Early appropriate antimicrobial therapy plays a critical role for patients with Staphylococcus aureus bloodstream infection (SAB). We aim to determine the optimal time-window for appropriate antimicrobial therapy and evaluate the effects of delayed therapy on adverse clinical outcomes (in-hospital mortality, sepsis, and septic shock) in children with SAB by propensity score matching (PSM) analysis. Receiver-operating characteristic was used to determine the cut-off point of the time to appropriate therapy (TTAT), the patients were divided into timely and delayed appropriate antimicrobial therapy (delayed therapy) groups accordingly. The PSM was used to balance the characteristics between the two groups, controlling the effects of potential confounders. Kaplan-Meier methods and Cox proportional hazards regression were applied to the matched groups to analyze the association between delayed therapy and clinical outcomes. Inverse probability of treatment weighting and propensity score covariate adjustment were also performed to investigate the sensitivity of the results under different propensity score-based approaches. In total, 247 patients were included in this study. The optimal cut-off point of TTAT was identified as 6.4 h, with 85.0% sensitivity and 69.2% specificity (AUC 0.803, 95% confidence interval 0.702-0.904). Eighty-seven (35.22%) of the 247 patients who received delayed therapy (TTAT ≥ 6.4 h) had higher in-hospital mortality (19.54% vs 1.88%, p < 0.001), higher incidences of sepsis (44.83% vs 15.00%, p < 0.001) and septic shock (32.18% vs 6.25%, p < 0.001) when compared to timely therapy (TTAT < 6.4 h) patients. After PSM analysis, a total of 134 episodes (67 in each of the two matched groups) were further analyzed. No statistically significant difference was observed in in-hospital mortality between delayed and timely -therapy groups (log-rank test, P = 0.157). Patients with delayed therapy had a higher incidence of sepsis or septic shock than those with timely therapy (log-rank test, P = 0.009; P = 0.018, respectively). Compared to the timely-therapy group, the hazard ratio and 95% confidence interval in delayed-therapy group were 2.512 (1.227-5.144, P = 0.012) for sepsis, 3.109 (1.166-8.290, P = 0.023) for septic shock. Conclusion: Appropriate therapy delayed 6.4 h may increase the incidence of sepsis and septic shock, with similar in-hospital mortality in patients with SAB. What is Known: • Staphylococcus aureus (S. aureus) is a major cause of bloodstream infections in children. Undoubtedly, early antimicrobial application plays a critical role in the treatment of children with Staphylococcus aureus bloodstream infections (SAB). • However, rapid, and aggressive administration of antimicrobials may lead to the overuse of these drugs and the emergence of multidrug-resistant microorganisms. Therefore, it is crucial to determine the optimal time-window for appropriate antimicrobial administration in children with SAB. Unfortunately, the optimal time-window for appropriate antimicrobial administration in children with SAB remains unclear. What is New: • Determining the optimal time-window for appropriate antimicrobial administration in patients with matched data variables is particularly important. The Propensity score matching (PSM) analysis effectively controls for confounding factors to a considerable extent when assessing the impact of treatment, thereby approximating the effects observed in randomized controlled trials. • To our knowledge, this is the first study using PSM method to assess the effects of delayed appropriate antimicrobial therapy on adverse outcomes in children with SAB. In low-risk populations with SAB, a delay of 6.4 h in appropriate therapy might increase the occurrence rate for sepsis and septic shock; however, no correlation has been found between this delay and an increased risk for hospital mortality.

References

Cobos-Carrascosa E, Soler-Palacin P, Larrosa M, Bartolome R, Martin-Nalda A, Frick M . Staphylococcus aureus Bacteremia in Children: Changes During Eighteen Years. Pediatr Infect Dis J. 2016; 34(12):1329-34. DOI: 10.1097/INF.0000000000000907. View

McMullan B, Bowen A, Blyth C, van Hal S, Korman T, Buttery J . Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children. JAMA Pediatr. 2016; 170(10):979-986. DOI: 10.1001/jamapediatrics.2016.1477. View

Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M . Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis. 2009; 49(7):997-1005. DOI: 10.1086/605555. View

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith C, French C . Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47(11):1181-1247. PMC: 8486643. DOI: 10.1007/s00134-021-06506-y. View

Schlapbach L, Weiss S, Wolf J . Reducing Collateral Damage From Mandates for Time to Antibiotics in Pediatric Sepsis-Primum Non Nocere. JAMA Pediatr. 2019; 173(5):409-410. DOI: 10.1001/jamapediatrics.2019.0174. View

Klompas M, Calandra T, Singer M . Antibiotics for Sepsis-Finding the Equilibrium. JAMA. 2018; 320(14):1433-1434. DOI: 10.1001/jama.2018.12179. View

Aratani T, Tsukamoto H, Higashi T, Kodawara T, Yano R, Hida Y . Association of methicillin resistance with mortality of hospital-acquired bacteremia. J Int Med Res. 2021; 49(11):3000605211058872. PMC: 8647257. DOI: 10.1177/03000605211058872. View

Kaasch A, Rieg S, Kuetscher J, Brodt H, Widmann T, Herrmann M . Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection. 2013; 41(5):979-85. DOI: 10.1007/s15010-013-0428-9. View

Lambregts M, Wijnakker R, Bernards A, Visser L, le Cessie S, de Boer M . Mortality after Delay of Adequate Empiric Antimicrobial Treatment of Bloodstream Infection. J Clin Med. 2020; 9(5). PMC: 7290963. DOI: 10.3390/jcm9051378. View

10.

Asner S, Desgranges F, Schrijver I, Calandra T . Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock. J Infect. 2021; 82(5):125-134. DOI: 10.1016/j.jinf.2021.03.003. View

11.

Benedetto U, Head S, Angelini G, Blackstone E . Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018; 53(6):1112-1117. DOI: 10.1093/ejcts/ezy167. View

12.

Sun J, Li J, Wu D, Deng F . Accuracy of SIRS, age-adapted pSOFA, and quick SOFA scoring systems for predicting outcomes in paediatric patients with sepsis: a meta-analysis. Pediatr Neonatol. 2021; 63(2):172-180. DOI: 10.1016/j.pedneo.2021.09.006. View

13.

Balamuth F, Scott H, Weiss S, Webb M, Chamberlain J, Bajaj L . Validation of the Pediatric Sequential Organ Failure Assessment Score and Evaluation of Third International Consensus Definitions for Sepsis and Septic Shock Definitions in the Pediatric Emergency Department. JAMA Pediatr. 2022; 176(7):672-678. PMC: 9112137. DOI: 10.1001/jamapediatrics.2022.1301. View

14.

Ye Z, Huang Y, Wang Y, Lu J, Wu J, Yu Z . Phenotype and Genotype of a Cohort of Chinese Children with Early-Onset Protein-Losing Enteropathy. J Pediatr. 2019; 208:38-42.e3. DOI: 10.1016/j.jpeds.2018.12.003. View

15.

Dale D . How I manage children with neutropenia. Br J Haematol. 2017; 178(3):351-363. DOI: 10.1111/bjh.14677. View

16.

Tang P, Lee C, Li C, Li M, Ko W, Lee N . Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia. J Microbiol Immunol Infect. 2015; 50(4):486-493. DOI: 10.1016/j.jmii.2015.08.014. View

17.

Hashemi S, Mamani M, Jamal-Omidi S, Niayesh A . Nosocomial bacterial infections and their antimicrobial resistance patterns in university hospitals of hamedan, iran. J Res Health Sci. 2012; 10(1):54-8. View

18.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

19.

Goldstein B, Giroir B, Randolph A . International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1):2-8. DOI: 10.1097/01.PCC.0000149131.72248.E6. View

20.

Weiss S, Peters M, Alhazzani W, Agus M, Flori H, Inwald D . Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020; 21(2):e52-e106. DOI: 10.1097/PCC.0000000000002198. View